Professional Documents
Culture Documents
NC our le
CN on ase
.o lin co
rg
/p e s mp
at u le
NCCN ie rv t
nt e
s/ ey
GUIDELINES su at
FOR PATIENTS
® 2020 rv
ey
Immunotherapy
Side Effects
Immune Checkpoint Inhibitors
Presented with support from:
It's easy to
get lost in the
cancer world
Let
NCCN Guidelines
for Patients®
be your guide
9
Step-by-step guides to the cancer care options likely to have the best results
An alliance of leading
Developed by doctors from
Present information from the
cancer centers across the NCCN cancer centers using NCCN Guidelines in an easy-
United States devoted to the latest research and years to-learn format
patient care, research, and of experience
education
For people with cancer and
For providers of cancer care those who support them
all over the world
Cancer centers
Explain the cancer care
that are part of NCCN:
Expert recommendations for options likely to have the
cancer screening, diagnosis, best results
NCCN.org/cancercenters
and treatment
Free online at
Free online at NCCN.org/patientguidelines
NCCN.org/guidelines
These NCCN Guidelines for Patients are based on the NCCN Guidelines® for Management of
Immunotherapy‑Related Toxicities (Version 1.2020, December 16, 2019).
© 2020 National Comprehensive Cancer Network, Inc. All rights reserved. NCCN Foundation seeks to support the millions of patients and their families
NCCN Guidelines for Patients and illustrations herein may not be reproduced in affected by a cancer diagnosis by funding and distributing NCCN Guidelines for
any form for any purpose without the express written permission of NCCN. No Patients. NCCN Foundation is also committed to advancing cancer treatment
one, including doctors or patients, may use the NCCN Guidelines for Patients for by funding the nation’s promising doctors at the center of innovation in cancer
any commercial purpose and may not claim, represent, or imply that the NCCN research. For more details and the full library of patient and caregiver resources,
Guidelines for Patients that have been modified in any manner are derived visit NCCN.org/patients.
from, based on, related to, or arise out of the NCCN Guidelines for Patients.
The NCCN Guidelines are a work in progress that may be redefined as often National Comprehensive Cancer Network (NCCN) / NCCN Foundation
as new significant data become available. NCCN makes no warranties of any 3025 Chemical Road, Suite 100
kind whatsoever regarding its content, use, or application and disclaims any Plymouth Meeting, PA 19462
responsibility for its application or use in any way. 215.690.0300
Endorsed by
Be the Match®
National Marrow Donor Program® (NMDP)/Be The Match® is the global
leader in providing a possible cure to patients with life-threatening blood
and marrow cancers, as well as other diseases. Our Be The Match Patient
Support Center provides support, information, and resources for patients,
caregivers, and families. BeTheMatch.org/one-on-one
Good Days
Good Days is proud to support this educational resource for patients and
their families and offers unwavering commitment to those who struggle with
chronic disease, cancer, and other life-altering conditions.mygooddays.org
Stupid Cancer
Stupid Cancer’s mission is to empower adolescents and young adults
affected by cancer by ending isolation and building community. Through
our innovative programming and strategic communications platforms, our
goal is to provide support, resources, education, and a sense of community
through online and in-person programming. stupidcancer.org
Contents
6 Checkpoint inhibitors and immune-related adverse events (irAEs)
12 Skin irAEs
19 Fatigue
23 Gastrointestinal irAEs
27 Endocrine irAEs
33 Lung irAEs
37 Musculoskeletal irAEs
51 Resources
57 Words to know
59 NCCN Contributors
61 Index
Immune checkpoint inhibitors have The immune system’s main job is to distinguish
become the standard of care for some normal, healthy cells from abnormal cancer
cancers. Like all cancer treatments, cells. Proteins on the surface of cancer cells—
ICIs have side effects. A number of PD-L1 for example—interact with proteins on
inflammatory reactions, or immune- immune cells. These interactions are called
related adverse events (irAEs), are immune checkpoints. The cancer cell proteins
prevent attack by “blindfolding” the immune
possible.
cells. ICIs remove the blindfold, allowing the
immune system to see and attack cancer cells.
Immune checkpoint inhibitors (ICIs) are a type
of immunotherapy. Immunotherapy is a modern
The two main types of ICIs currently used for
approach to cancer treatment that harnesses
cancer immunotherapy are:
the power of your own immune system to
kill cancer cells. Scientists have discovered
PD-1/PD-L1 inhibitors
different ways to use the immune system
against cancer. In addition to ICIs, other types The CTLA-4 inhibitor ipilimumab (Yervoy®)
of immunotherapy include:
PD-1 inhibitors include:
CAR T-cell therapy
Cemiplimab (Libtayo®)
Monoclonal antibodies
Nivolumab (Opdivo®)
Cancer vaccines
Pembrolizumab (Keytruda®)
Oncolytic virus therapy
PD-L1 inhibitors include:
ICIs are the focus of this patient guide. NCCN
Guidelines for Patients Immunotherapy Side
Atezolizumab (Tecentriq®)
Effects: CAR T-Cell Therapy is also available:
Avelumab (Bavencio®)
Durvalumab (Imfinzi®)
used immunosuppressants for this purpose and disease. Immunoglobulins are usually
are described next. The choice of immune- given intravenously. This is called intravenous
suppressing therapy will depend on the type of immunoglobulin therapy (IVIG).
irAE and how severe it is.
Mycophenolate mofetil (CellCept®)
Infliximab (Remicade®) While originally used in the management of
Infliximab is a prescription medicine called a patients with organ transplants, mycophenolate
tumor necrosis factor (TNF) blocker. It works by mofetil is now used to treat a variety of
blocking a protein in your immune system that autoimmune diseases. It is the preferred
can cause inflammation (TNF-alpha). immunosuppressant for treating liver
inflammation (hepatitis) caused by ICI therapy
Infliximab is given intravenously, meaning it is that does not respond to steroid therapy. It is
put directly into the bloodstream through a vein. taken by mouth.
You will be monitored closely after receiving
an infusion of infliximab. If needed, two extra Rituximab (Rituxan®)
doses may be given 2 weeks and 6 weeks after Rituxan is an antibody therapy. It works by
the first infusion. destroying B cells (a type of white blood cell)
that make autoantibodies. Autoantibodies
If you have immune-related hepatitis, you are antibodies that attack your own cells by
should not receive infliximab or any other TNF mistake. Rituximab destroys B cells that are
blockers. However, other immunosuppressants carrying the CD20 marker.
may be helpful for managing certain side
effects. For example, a different type of Tocilizumab (Actemra®)
medication called vedolizumab (Entyvio®) may Interleukin-6, or IL-6, is an immune protein
be an option for treating immune-related colitis called a cytokine that can cause inflammation.
in people with hepatitis. Tocilizumab is a prescription medicine that
inhibits, or blocks, IL-6. Tocilizumab is given
Infliximab can re-activate the hepatitis B virus. intravenously. It may be used to treat lung
Your blood will be tested for the hepatitis B and inflammation (pneumonitis) that does not
C viruses. If you are a hepatitis B or C carrier, respond to steroid therapy.
you will be monitored during treatment and for
a few months after finishing treatment. Anti-thymocyte globulin (ATG)
ATG may be used to treat heart inflammation
Infliximab can also re-activate tuberculosis. You (myocarditis) that does not improve with steroid
will be tested for tuberculosis before starting therapy. Myocarditis is an uncommon but
treatment with infliximab. It is not necessary to serious irAE. ATG is serum from blood that
have the results before starting treatment. contains antibodies that attach to human T
cells. It is most often used to lower the risk of
Immunoglobulin replacement therapy graft-versus-host disease (GVHD) after a stem
In immunoglobulin replacement therapy cell transplant, and after a kidney transplant to
infusions of antibody-containing plasma from help keep the body from rejecting the kidney.
blood are given to help your body fight infection
Skin disorders are the most common (ADLs). Essential tasks such as bathing and
side effect of immune checkpoint dressing are “self-care” ADLs. Higher level
inhibitor (ICI) therapy. Most are mild tasks and activities such as grocery shopping,
managing finances, and home maintenance are
and can be managed without stopping
known as “instrumental” ADLs.
immunotherapy. While rare, very serious
skin reactions can occur.
Rash
Inflammatory skin conditions triggered by
immunotherapy usually start within the first few A rash that has both flat patches (macules) and
weeks of treatment. Some ICIs are more likely bumps (papules) is called a maculopapular
to cause skin problems than others. The risk rash. It is one of the most common skin irAEs.
of getting a very serious skin problem is low, You may or may not have other symptoms,
however, no matter which ICI you are taking. such as itching, burning, and tightness.
If you develop symptoms of a skin disorder Your doctor will consider the following in order
such as rash, itching, or blisters, your doctor to determine if the rash is mild, moderate, or
will perform a broader skin exam. It is important severe:
to identify all problem areas and to determine
how much of your body is affected. How widespread is the rash? How much of
your body does it cover?
A comprehensive total body skin exam
Do you have any other symptoms, such as
includes:
itching, burning, or tightness?
The inside of your mouth (“oral mucosa”) How much is the rash impacting your
ability to do day-to-day tasks?
Hair and scalp
Fingernails and toenails
Treatment
In order to help track healing progress, your
Mild rash
doctor may take photographs of the inflamed
A maculopapular rash covering a small area of
areas.
the body (less than 10 percent) is considered
mild. You can continue immunotherapy. A
Tell your doctor if you’ve had an inflammatory
moderate-strength steroid cream or gel should
skin disorder in the past. If you have, it is a
be applied to all areas of the rash. If the rash is
good idea to see a see a dermatologist on a
itchy, taking an oral antihistamine can help.
regular basis.
Moderate rash
A rash covering a larger area of the body
(10 to 30 percent) that is interfering with
instrumental ADLs is considered moderate.
You can continue immunotherapy. Your doctor
may prescribe a steroid cream or gel, an oral
steroid, or both. emollient
If a topical steroid is used, a moderate- to high- (eh-MOL-ee-unt)
strength dose is recommended. If treatment
with an oral steroid is planned, prednisone 0.5 Emollients can be found in lotions,
to 1 mg/kg/day is recommended. If the rash creams, ointments, and gels. They
is itchy, taking an oral antihistamine can help help soothe, soften, moisturize, and
reduce the itchiness. protect the skin from irritation.
Severe rash
A rash covering more than 30 percent of your
body that is interfering with self-care ADLs such Treatment with both a high-potency
as bathing and dressing is considered severe. steroid cream or gel and an oral steroid is
In-hospital care may be needed. ICI therapy recommended. A dose of 0.5 to 1 mg/kg/day
will be stopped until further notice. A tiny piece of oral prednisone is given to start. If there is
of inflamed skin may be removed and tested (a no improvement, your doctor may increase the
biopsy). dose up to 2 mg/kg/day.
Maculopapular rash
Blisters
Activities of
A blister is a fluid-filled sac in the outer layer Daily Living (ADLs)
of skin. Blistering, especially in the mouth
or genital area, is a medical emergency. It
could be a sign of a life-threatening blistering Self care
disorder called Stevens-Johnson syndrome
(SJS).
Guide 1
Blood tests recommended for fatigue
Complete blood count A CBC measures the levels of red blood cells, white blood cells,
(CBC) and platelets in your blood. It can detect a range of diseases and
disorders and provides information on your overall health.
Comprehensive metabolic A CMP is a group of over 10 different blood tests that provide an
panel (CMP) overall picture of your body chemistry and metabolism.
Free T4 test Thyroxine (T4) is one of two major hormones produced by the
thyroid. If the thyroid gland does not make enough T4, symptoms of
hypothyroidism including fatigue can occur.
Cortisol test Cortisol is a hormone that helps you respond to stress, fight
infection, regulate blood sugar, and other functions. Cortisol should
be measured in the morning, when the level is at its highest.
Morning testosterone test This test is used to detect an abnormal testerone level. Testosterone
(recommended for men) should be measured in the morning, when the level is at its highest.
Review
Fatigue, or tiredness, is a common side
effect of checkpoint inhibitors.
Evaluating fatigue includes a physical
exam, blood tests, and a review of
medications you are taking.
Immunotherapy can be continued for mild
fatigue, but might be temporarily stopped
for moderate fatigue.
ICI therapy will be stopped temporarily–
possibly permanently–for severe fatigue.
Severe fatigue may be a sign of a
hormone-related (endocrine) problem.
Urgent testing and treatment may be
needed.
Abdominal pain
In order to evaluate your symptoms, it is Your doctor may also order a lactoferrin test.
important to determine your starting, or Lactoferrin is a protein found in milk (human
baseline, bowel habits. Because everyone’s and cow), saliva, tears, mucus, and bile. It may
bowel habits are somewhat different, it’s the help fight infection and inflammation.
increase in the number of bowel movements
per day that’s important, along with other If you have moderate or severe colitis, you
symptoms. may have computed tomography (CT) of your
abdomen and pelvis.
If you have chronic constipation or constipation
due to opioid pain medication, your symptoms
Treatment
may be different. You may have colitis that
presents as a daily bowel movement and
Mild symptoms
abdominal cramping. It is important that you
Your doctor might recommend temporarily
have a good understanding of your baseline.
stopping the ICI for mild symptoms. For some
people, mild symptoms may mean 1 to 3 bowel
movements above normal per day and no
colitis symptoms.
Treatment with anti-diarrheal medication for Endoscopy may be used to monitor how well
2 to 3 days is recommended. Loperamide you are healing and to help determine how long
(Imodium®) and diphenoxylate/atropine to continue treatment.
(Lomotil®) are commonly used anti-diarrheal
medications. It is important to stay hydrated. Severe symptoms
Drinking lots of fluids is recommended. For more severe symptoms, ICI therapy should
You will be closely monitored. If there is no be stopped. Severe symptoms may include:
improvement after 2 to 3 days, your doctor may
test your stool for infection and lactoferrin. More than 6 bowel movements above
normal per day
If testing does not find infection, you can
Colitis symptoms
continue anti-diarrheal medication and fluids.
Treatment with mesalamine (Pentasa®) or Symptoms interfering with activities of
cholestyramine (Prevalite®) may be added. daily living (ADLs)
Mesalamine is an anti-inflammatory medicine;
cholestyramine is a cholesterol-lowering Very severe symptoms and complications are
medicine. also possible. In-hospital care may be needed.
Depending on your symptoms, immunotherapy
Moderate symptoms with the type of ICI you are receiving may be
If you’re having 4 to 6 bowel movements above permanently stopped.
normal per day and also have colitis symptoms,
your symptoms are considered moderate. Corticosteroid therapy will be started. If your
Immunotherapy will be stopped. Corticosteroid symptoms haven’t improved after 2 days of
therapy (1–2 mg/kg/day) will be started. If your steroid therapy, your doctor may add treatment
symptoms haven’t improved after 2 to 3 days of with one of the following:
steroid therapy, your doctor may add treatment
with one of the following: Infliximab (Remicade®)
Vedolizumab (Entyvio®)
Infliximab (Remicade®)
Vedolizumab (Entyvio®) Endoscopy may be used to monitor how well
you are healing and to help determine how long
Both are given intravenously. You will have to continue treatment.
a tuberculosis test before receiving either of
these, but it is not necessary to have the results A stool (fecal) transplant may be an option
before starting treatment. for colitis that does not respond to immune-
suppressing treatment, or that returns after
If you receive either of these, your doctor may treatment. This will be based on the center
advise you to slowly stop steroid therapy in less where you are receiving treatment and the
than 4 weeks. This may reduce the chance of expertise of the health care providers.
getting an infection. There is no standard length
of treatment with Remicade® or Entyvio®. You
may have up to three doses.
Hepatitis Review
A less common gastrointestinal side effect Diarrhea and colitis are among the most
of checkpoint inhibitors is liver inflammation common irAEs.
(hepatitis). Unlike diarrhea and colitis,
Diarrhea refers to having more bowel
hepatitis does not typically cause symptoms.
movements than normal, which may be
It is most often found by blood tests used
watery.
to monitor the levels of two liver enzymes—
alanine transaminase (ALT) and aspartate Colitis is inflammation of the inner lining of
transaminase (AST). Having higher-than- the large intestine (the colon). Symptoms
normal levels of ALT and AST is called include watery diarrhea, cramping, and
transaminitis. It may be a sign of liver urgency.
inflammation or damage.
Anti-diarrheal medication is used to treat
mild diarrhea. Treatment with mesalamine
Treatment will depend on how high above
(Pentasa®) or cholestyramine (Prevalite®)
normal your liver enzymes are. Corticosteroid
may be added if there is no improvement.
therapy may be used for moderate,
transaminitis, and is essential for severe or life- Immunotherapy will be stopped for
threatening transaminitis. moderate colitis. Corticosteroid therapy
will be started. If your symptoms do not
Bilirubin is a yellowish substance found in improve, treatment with infliximab or
blood. Any type of liver function problem can vedolizumab may be added.
cause it to build up in your blood. If you have
Hepatitis is inflammation of the liver.
transaminitis and a higher-than-normal bilirubin
Higher-than-normal levels of liver enzymes
level, immunotherapy should be permanently
(transaminitis) may be a sign of liver
stopped. In-hospital treatment is needed. This
damage.
excludes people with a genetic condition called
Gilbert’s syndrome, which causes high levels of Depending on how high above normal
bilirubin in the blood. your liver enzymes are, it may be
necessary to stop immunotherapy,
Steroid therapy will be started (2 mg/kg/day). possibly permanently.
Your liver enzymes will be closely monitored. If
Corticosteroid therapy may be used for
there is no improvement after 3 days of steroid
moderate transaminitis, and is essential for
therapy, your doctor may add mycophenolate
severe or life-threatening transaminitis.
mofetil (CellCept®), an immune-suppressing
medication. Infliximab is not used for liver
problems.
Immune checkpoint inhibitor (ICI) If you have a blood sugar level of 200 mg/
therapy can adversely affect your body’s dL after fasting, or a random (non-fasting)
hormone-producing organs and glands measurement above 250 mg/dL, you may have
(endocrine system). Endocrine irAEs are testing for diabetic ketoacidosis (DKA). DKA
fairly common during ICI therapy. is a serious and potentially life-threatening
condition. It occurs when the body starts
breaking down fat too quickly and toxic acids
(ketones) build up in the blood and urine.
High blood sugar and diabetes Symptoms of DKA are listed in Guide 3.
Vomiting
A slightly high blood sugar level may be due to
corticosteroid therapy, or to pre-existing type Confusion
2 diabetes. If steroid therapy (or diabetes) has
caused your blood sugar level to go up, but Abdominal pain
it is still below 200 mg/dL, you can continue
Dry skin
immunotherapy.
Dry mouth
You may benefit from changes to your diet
and lifestyle. Eating healthy and exercising Increased heart rate
can help keep blood sugar under control. If Fruity odor on the breath
needed, medications may also be an option for
managing your blood sugar.
Thyroid gland
Hypophysitis
Guide 4
The pituitary gland is an important hormone- Hypophysitis symptoms
producing gland in the brain. While rare, the
New-onset Headache
pituitary gland can become inflamed. This is symptoms
called hypophysitis. Permanent damage to the Photophobia
pituitary gland can occur. The symptoms of
hypophysitis are listed in Guide 4. Dizziness
Nausea/emesis
Testing for suspected hypophysitis includes a
number of blood tests, and possibly magnetic Fevers
resonance imaging (MRI) of your brain.
Anorexia
Immunotherapy will be stopped until new-onset Visual field cuts
symptoms are gone. If you have symptoms,
corticosteroid therapy will be started. If your Severe fatigue
new symptoms are severe, high-dose steroids
Long-term Weight loss
are recommended. symptoms
Fatigue
When your symptoms are gone—typically in
about 1 to 2 weeks—you will be transitioned
to hormone replacement therapy. Hormone
replacement therapy for pituitary gland damage
may be needed for the rest of your life.
An adrenal gland sits on top of each kidney. Addison’s disease is treated with medication
These glands make hormones that are to replace the hormones not being made by
essential for the body to function properly, the body. This hormone replacement therapy
including cortisol. Cortisol helps you respond to typically includes:
stress, fight infection, and regulate blood sugar.
Oral hydrocortisone or prednisone to
In primary adrenal insufficiency (also called replace cortisol
Addison’s disease), the adrenal glands do not
Oral fludrocortisone acetate to replace
make enough cortisol, and often not enough of
aldosterone
a different hormone called aldosterone.
Immunotherapy can be restarted when
Symptoms of adrenal insufficiency include:
hormone levels have returned to normal.
Hormone replacement therapy is usually
Weight loss
needed for the rest of your life. Your doctor will
Dark areas of skin (hyperpigmentation) determine the lowest dose needed to prevent
symptoms of adrenal insufficiency.
Severe fatigue
Gastrointestinal problems, such as In people without Addison’s disease, the
nausea, vomiting, and diarrhea adrenal glands make significantly more
cortisol in response to infection, illness,
Lightheadedness or fainting
injury, or trauma to the body. Your doctor may
Cortisol
Pulse oximetry
A pulse oximeter
measures the
amount of oxygen
being carried by
red blood cells
by shining light
through your finger.
a bronchoalveolar lavage (BAL). The collected suggests widespread pneumonitis, your doctor
fluid will be sent to a laboratory to be tested for may prescribe steroids to prevent symptoms
infection. If there is a possibility that cancer has before they start.
spread to the lungs, a biopsy will be performed
during bronchoscopy. If you have symptoms of pneumonitis (ie,
shortness of breath, cough, chest pain, fever),
immunotherapy will be stopped. Corticosteroid
Computed tomography
therapy will be started. If steroid therapy works
Your may also have computed tomography
well and you no longer have symptoms, you
(“CT scan” or “CAT scan”) of your chest. If
may be able to resume immunotherapy.
so, a liquid called a contrast agent will also
be used. It will either be put directly into your
Pneumonitis is considered severe if you require
bloodstream through a vein, or given to you to
extra oxygen to breathe and your symptoms
drink. It will help make the CT images clearer.
are limiting your ability to do essential self-care
tasks. An extremely serious respiratory crisis is
considered life-threatening pneumonitis.
Treatment In-hospital care is needed for severe or life-
threatening pneumonitis. Immunotherapy
Pneumonitis that does not cause symptoms,
will be permanently stopped. Intravenous
but that can be seen on imaging tests, is
corticosteroid therapy will be started. If there is
considered mild. Your doctor may recommend
no improvement within 48 hours, treatment with
temporarily stopping ICI therapy. Or, a watch-
one of the following may be added:
and-wait approach may be taken. If imaging
Bronchoalveolar lavage
Immunotherapy with immune checkpoint Your doctor will carefully examine the painful
inhibitors (ICIs) can cause inflammation or swollen joint(s) in order to see if it functions
of the joints, tendons, ligaments, properly. You may have an x-ray, ultrasound,
bones, and muscles. This chapter or magnetic resonance imaging (MRI) of the
describes these musculoskeletal (also affected joint(s).
called rheumatic) side effects and their
treatment. Treatment
Immunotherapy can be continued for
inflammatory arthritis that is mild or only affects
one joint. Nonsteroidal anti-inflammatory drugs
Inflammatory arthritis (NSAIDs) can help relieve the inflammation. If
there is no improvement with NSAID therapy,
Inflammatory arthritis is not a single disease. your doctor may prescribe low-dose steroid
It refers to a group of disorders in which the therapy. Steroid injections may also be an
immune system attacks the joints, causing option for relieving inflammation, depending on
inflammation. Major types include: the number of inflamed joints and their location.
This involves injecting steroids directly into the
Rheumatoid arthritis painful or swollen joint with a needle.
Psoriatic arthritis
While ICI therapy can be continued for mild
Ankylosing spondylitis inflammation, it may be temporarily stopped
if the arthritis is somewhat more severe
Gout
(“moderate”). Corticosteroid therapy with
Lyme disease prednisone for 4 to 6 weeks is recommended.
If your symptoms haven’t improved by week 4
Lupus
of steroid therapy, a specialist (rheumatologist)
may be consulted.
Inflammatory arthritis is different from
osteoarthritis, which is caused by physical use
If the arthritis is preventing you from carrying
of the joint(s) over many years. Also unlike
out activities of daily living (ADLs) and
osteoarthritis, inflammatory arthritis often
imaging tests show joint erosion, the arthritis
affects joints throughout the body, rather than
is considered severe. Severe inflammatory
one or two joints. Symptoms of inflammatory
arthritis can lead to irreversible joint damage.
arthritis include:
Immunotherapy will be stopped until further
Joint pain and swelling
notice. Steroid therapy (1 mg/kg/day) will be
Tendon pain and swelling started. If there is no improvement by week 2,
treatment with other disease-modifying anti-
Stiffness after rest/inactivity
rheumatic drugs (DMARDs) may be added.
Improvement with heat Steroid injections may also be used.
Polymyalgia rheumatica
Blood tests
Guide 5
Lung function tests Myasthenia gravis symptoms
Heart function tests, such as an
electrocardiogram (ECG) Drooping of the upper eyelid (ptosis)
Encephalitis
Encephalitis is inflammation of the brain. Guide 6
Symptoms can range from mild confusion to Encephalitis symptoms
very serious brain function problems. See Confusion
Guide 6.
Changes in behavior
It is important to rule out infection–especially
Headaches
viruses–as the cause of encephalitis. Testing
typically includes: Seizures
While waiting for test results in the hospital, Symptoms of transverse myelitis include:
your doctor may start treatment with an
antiviral drug called acyclovir. A trial of steroid Pain
therapy (methylprednisolone 1–2 mg/kg/
Weakness in the legs and sometimes the
day) is recommended. If your symptoms are
arms
severe or getting worse, your doctor may
order intravenous immune globulin (IVIG) or Sensory problems
plasmapheresis.
Bladder and bowel problems, such as
constipation or retaining urine
If your test results are positive for a particular
antibody (autoimmune encephalopathy
Testing for suspected transverse myelitis
antibody) or if you are not improving with
typically includes:
Uveitis Episcleritis
The most common type of uveitis is iritis. Iritis is While uncommon, it is possible for inflammation
inflammation of the colored part of the eye that of the white of the eye (episcleritis) to impair
circles the pupil (the iris). The iris is the front your vision. If the inflammation causes
part of the uvea. ICI therapy will be stopped your eyesight to worsen somewhat, but not
until further notice. In addition to steroid eye drastically, immunotherapy will be stopped
until further notice. You will be evaluated
biopsy. If causes of high creatinine levels other pancreatitis, the body’s immune system attacks
than immunotherapy have been ruled out, the pancreas, causing inflammation. While rare,
corticosteroid therapy with oral prednisone is acute pancreatitis can occur during ICI therapy.
recommended.
Mild symptoms include:
In-hospital care is needed for severe or life-
threatening acute kidney injury. Immunotherapy Nausea
will be permanently stopped. Corticosteroid
Bloating
therapy will be started. You may have a kidney
biopsy. Burping
Abdominal pain
Back pain
Pancreatitis
The levels of these enzymes will be monitored
The pancreas is a large gland located behind with blood tests during ICI therapy. Mild
the stomach. Among other jobs, the pancreas elevations do not typically cause symptoms and
makes substances called enzymes that help do not require treatment.
digest food. Pancreatic amylase helps to digest
sugars (carbohydrates). Pancreatic lipase helps In-hospital care is needed for acute
to digest fat. pancreatitis. ICI therapy may be stopped,
possibly permanently.
High levels of pancreatic enzymes can be
a sign of acute pancreatitis. In autoimmune
The kidneys
Review
ICI side effects affecting the brain, heart,
eyes, kidneys, and pancreas are rare but
potentially serious.
Myasthenia gravis causes muscle
weakness in the eyes, face, throat, and
throughout the body.
GBS is a serious muscle weakness
disorder that can affect the arms and legs,
face, breathing muscles, and eye nerves.
The most common irAEs affecting the
eyes are dry eye and uveitis, a type of eye
inflammation.
Myocarditis is a rare but serious
condition in which the heart muscle (the
myocardium) becomes thick and inflamed.
High levels of pancreatic enzymes can be
a sign of acute pancreatitis. While rare,
acute pancreatitis can occur during ICI
therapy.
The pancreas
ICIs now play a major role in cancer care. They When to contact your
are used to treat advanced melanoma, lung
cancer, urothelial cancers, kidney cancers, cancer care team
and others. While their anti-cancer benefits are
important, they come with a unique range of
side effects. 3
If you develop signs and symptoms, such as:
• Severe fatigue
Understanding the possible side effects of ICI • Headache
therapy can help you to spot symptoms early
• Rash
and report them to your care team.
• Cough
• Shortness of breath
• Chest pain
Questions to ask • Abdominal bloating
It is normal to have lots of questions about • Change in bowel habits
immunotherapy with ICIs. Possible questions • Weight loss
to ask your doctor are listed on the following • Vision changes or eye pain
pages. Feel free to use these questions or
come up with your own. • Severe muscle weakness
• Severe muscle or joint pains
Following the questions is a listing of websites • Mood changes
that provide information for patients about ICIs
and their effects.
3
If you are seen by a new health care provider
3
If you are prescribed any new medication
3
If you are admitted to the hospital
3
Before getting any immunizations or
vaccinations
2. What are the irAEs of ICI therapy? When do they start? How long do they usually last?
Websites
Stupid Cancer
stupidcancer.org
NCCN Contributors
This patient guide is based on the NCCN Clinical Practice Guidelines in Oncology (NCCN
Guidelines®) for Immunotherapy-Related Toxicities. It was adapted, reviewed, and published with
help from the following people:
Dorothy A. Shead, MS Erin Vidic, MA Tanya Fischer, MEd, MSLIS Susan Kidney
Director, Patient Information Medical Writer Medical Writer Design Specialist
Operations
Rachael Clarke Kim Williams
Laura J. Hanisch, PsyD Senior Medical Copyeditor Creative Services Manager
Medical Writer/Patient
Information Specialist
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Immunotherapy‑
Related Toxicities (Version 1.2020, December 16, 2019) were developed by the following NCCN
Panel Members:
Huntsman Cancer Institute Siteman Cancer Center at Barnes- Yale Cancer Center/
at the University of Utah Jewish Hospital and Washington Smilow Cancer Hospital
Salt Lake City, Utah University School of Medicine New Haven, Connecticut
877.585.0303 St. Louis, Missouri 855.4.SMILOW • yalecancercenter.org
huntsmancancer.org 800.600.3606 • siteman.wustl.edu
Index
adrenal gland 8, 30–31 Gilbert’s syndrome 26
aldolase 39 Guillain-Barré syndrome 44
amylase 50 hepatitis 10, 24–26
aseptic meningitis 44 hormone replacement therapy 30–32
bilirubin 26 hyperglycemia 27, 31
blister 13, 16–17, 57 hypophysitis 28, 32
breastfeeding 53 intravenous immunoglobulin (IVIG) 10, 35
bronchoalveolar lavage (BAL) 35–36 lactoferrin 24–25
bronchoscopy 34–35 lichenification 15
colitis 8, 10, 23–25 maculopapular rash 13–14, 17–18
cortisol 31 mesalamine 25–26
creatine kinase 39 myalgia 39, 41
CTLA-4 7–8, 11 myasthenia gravis 44, 47, 51
diabetes 9, 28 myocarditis 10, 47–48, 51
diabetic ketoacidosis 28 myositis 39, 41, 47, 56
diarrhea 8, 23–25, 25, 31, 54 nephritis 49
disease-modifying anti-rheumatic drugs nonsteroidal anti-inflammatory drug
(DMARDs) 38 (NSAID) 9, 38–39, 41
duloxetine 44 osteoporosis 9
encephalitis 45 pancreatitis 50, 51
endoscopy 25 PD-1/PD-L1 7–8, 11
episcleritis 47–48 photophobia 29, 45, 48
fatigue 8, 19–22, 29–32, 46, 48, 52, 54 polymyalgia rheumatica 40
gabapentin 15, 4r pregabalin 16, 45
gastritis 9 pregnancy 54
giant cell arteritis 40 proptosis 48
Immunotherapy
Side Effects
Immune Checkpoint Inhibitors
2020
NCCN Foundation gratefully acknowledges the following corporate supporters for helping to make available these NCCN Guidelines
for Patients: AstraZeneca; EMD Serono, Inc.; Jazz Pharmaceuticals, Inc.; Pfizer Inc; Regeneron Pharmaceuticals, Inc. and
Sanofi Genzyme. NCCN independently adapts, updates and hosts the NCCN Guidelines for Patients. Our corporate supporters do
not participate in the development of the NCCN Guidelines for Patients and are not responsible for the content and recommendations
contained therein.
PAT-N-1251-0520